Get the Stockscreener App
78.01
1.00%
0.77
After Hours:
78.01
Solventum Corp stock is traded at $78.01, with a volume of 636.61K.
It is up +1.00% in the last 24 hours and up +3.20% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$77.24
Open:
$78
24h Volume:
636.61K
Relative Volume:
0.40
Market Cap:
$13.51B
Revenue:
$8.28B
Net Income/Loss:
$1.43B
P/E Ratio:
9.5551
EPS:
8.1642
Net Cash Flow:
$-203.00M
1W Performance:
-4.06%
1M Performance:
+3.20%
6M Performance:
-1.14%
1Y Performance:
+5.52%
1-Day Range:
$77.17
$78.70
1-Week Range:
$76.77
$81.23
52-Week Range:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
78.01 | 13.51B | 8.28B | 1.43B | -203.00M | 8.1642 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-26 | Initiated | Rothschild & Co Redburn | Sell |
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
SOLV|Solventum Corp|Price:78.010|Chg%:+0.750 - TradingKey
Solventum Corporation Revenue Breakdown – MIL:1SOLV - TradingView
3M stock steadies as investors weigh post-spin earnings and healthcare separation - AD HOC NEWS
SOLN5759819 Bond Profile — Key Metrics - TradingView
SOLN5957383 Bond Profile — Key Metrics - TradingView
SOLN5957403 Bond Profile — Key Metrics - TradingView
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now - The Globe and Mail
3M stock trades steady as restructuring and health-care spin shape outlook - AD HOC NEWS
3M stock holds steady as litigation charge and healthcare spin-off reshape outlook - Ad-hoc-news.de
SOLN5759822 Bond Profile — Key Metrics - TradingView
3 Reasons SOLV is Risky and 1 Stock to Buy Instead - StockStory
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
SOLN5957968 Bond Profile — Key Metrics - TradingView
Solventum’s Q2 2026 Earnings: What to Expect - Barchart.com
Solventum Reports Fourth Quarter 2024 Financial Results and Intr - GuruFocus
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
SOLN5759602 Bond Profile — Key Metrics - TradingView
Frontier tech research, news & data - MLQ.ai
SOLN5759824 Bond Profile — Key Metrics - TradingView
SOLN5759603 Bond Profile — Key Metrics - TradingView
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
SOLN5957404 Bond Profile — Key Metrics - TradingView
Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune
Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026 - BioSpace
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Solventum to report Q2 FY26 earnings on August 5, 2026 - scanx.trade
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
SOLN5957967 Bond Profile — Key Metrics - TradingView
SOLN5759820 Bond Profile — Key Metrics - TradingView
BTIG Adjusts Solventum Price Target to $91 From $89, Maintains Buy Rating - marketscreener.com
Solventum Corporation (SOLV) Stock Analysis: Evaluating a 7% Potential Upside Amidst Sector Challenges - DirectorsTalk Interviews
Solving A Lackluster Growth Outlook Should Be Solventum’s Next Priority (NYSE:SOLV) - Seeking Alpha
The Bull Case For Solventum (SOLV) Could Change Following Dual Russell 2500 Index Inclusion - simplywall.st
Solventum Foundation and America’s ToothFairy Join Forces - Dentistry Today
Solventum Corporation (SOLV) Stock Analysis: Exploring a 4.96% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Solventum (SOLV) Joins Russell Indices, Is Its 6% Undervalued View Still Compelling? - simplywall.st
solventum-logo-horz-clr-rev-rgb - Dentistry UK
Solventum (SOLV) Is Up 6.4% After Russell 2500 Value Inclusion Shifted Its Healthcare Role - simplywall.st
Solventum stock: Is SOLV underperforming the healthcare sector? - MSN
Solventum Corporation(NYSE: SOLV) added to Russell 2500 Index - marketscreener.com
Solventum Corp (SOLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
3M updates health spinoff tax details, shares stay on investor radar - Ad-hoc-news.de
Price to sales forward of Solventum Corporation – NYSE:SOLV - TradingView
Solventum Corporation Actuals & Estimates (NYSE:SOLV) - TradingView
Enterprise value to revenue forward of Solventum Corporation – NYSE:SOLV - TradingView
SOLV Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Solventum Corporation – NYSE:SOLV - TradingView
Solventum (SOLV) Short Interest & Short Float | Updated Jun 2026 $SOLV - MarketBeat
Solventum Stock Sinks as Investors Question Its Health - TipRanks
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):